| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
george_church [2023/01/16 19:56] liam | george_church [2023/01/22 21:06] (current) liam [Jeffrey Epstein] |
|---|
| On October 30, 2017, Church was awarded the title of Honorary Professor at [[Zhejiang University]].((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj)) After the award ceremony, Church delivered a keynote speech titled “Technologies for Reading & Editing DNA and Medical Applications” at [[Xinglin Forum]], a high-level academic activity hosted by ZJU’s School of Medicine. | On October 30, 2017, Church was awarded the title of Honorary Professor at [[Zhejiang University]].((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj)) After the award ceremony, Church delivered a keynote speech titled “Technologies for Reading & Editing DNA and Medical Applications” at [[Xinglin Forum]], a high-level academic activity hosted by ZJU’s School of Medicine. |
| |
| | On May 1, 2018, Church co-led the second [[Genome Project-write]] (GP-write) "Scientific Working Meeting" at the [[Center of Excellence for Engineering Biology]], where he reportedly networked with [[Bryan Bishop]] and [[Max Berry]].((//GP-write Scientific Working Meeting | May 1, 2018.// The Center of Excellence for Engineering Biology. Retrieved January 22, 2023, from https://archive.ph/LOm33)) ((Shanks, P. (2019, February 8). //The Bitcoin Baby Project.// Center for Genetics and Society. https://web.archive.org/web/20230122195002/https://www.geneticsandsociety.org/biopolitical-times/bitcoin-baby-project)) In response to the pair's request for advice on their new [[designer baby]] startup, Church told them to consult with ethicists.((Regalado, A. (2019, February 1). //The DIY designer baby project funded with Bitcoin.// MIT Technology Review. https://archive.ph/lgB0w)) |
| ==== COVID-19 ==== | ==== COVID-19 ==== |
| |
| | [[AltLabs]] | Scientific Advisor((Alley, E. C., Turpin, M., Liu, A. B., Kulp-McDowall, T., Swett, J., Edison, R., Von Stetina, S. E., Church, G. M., & Esvelt, K. M. (2020). //A machine learning toolkit for genetic engineering attribution to facilitate biosecurity.// Nature Communications, 11(1). https://doi.org/10.1038/s41467-020-19612-0)) | | | [[AltLabs]] | Scientific Advisor((Alley, E. C., Turpin, M., Liu, A. B., Kulp-McDowall, T., Swett, J., Edison, R., Von Stetina, S. E., Church, G. M., & Esvelt, K. M. (2020). //A machine learning toolkit for genetic engineering attribution to facilitate biosecurity.// Nature Communications, 11(1). https://doi.org/10.1038/s41467-020-19612-0)) | |
| | [[medical_technology_companies:Alveo Technologies]] | Advisor((Chiarello, R. (2019, May 1). //Famed American Geneticist, George Church, Joins Alveo’s Scientific Advisory Board.// Alveo Technologies. https://archive.ph/inv3o)) | | | [[medical_technology_companies:Alveo Technologies]] | Advisor((Chiarello, R. (2019, May 1). //Famed American Geneticist, George Church, Joins Alveo’s Scientific Advisory Board.// Alveo Technologies. https://archive.ph/inv3o)) | |
| | | [[ARCH Venture Partners]] | - | |
| | [[pharmaceutical_companies:AuraVax Therapeutics]] | Scientific Advisor((//Company.// AuraVax. Retrieved November 28, 2022, from https://web.archive.org/web/20221128184427/https://www.auravax.com/company/)) | | | [[pharmaceutical_companies:AuraVax Therapeutics]] | Scientific Advisor((//Company.// AuraVax. Retrieved November 28, 2022, from https://web.archive.org/web/20221128184427/https://www.auravax.com/company/)) | |
| | [[Betterhumans]] | Scientific Advisor((//Meet Our Team.// Betterhumans. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074336/https://www.betterhumans.org/team.html)) | | | [[Betterhumans]] | Scientific Advisor((//Meet Our Team.// Betterhumans. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074336/https://www.betterhumans.org/team.html)) | |
| | [[medical_technology_companies:Complete Genomics]] | Advisory board member((//Advisory Board.// Complete Genomics. Retrieved November 27, 2022, from https://web.archive.org/web/20221127145415/https://www.completegenomics.com/about-us/complete-genomics-advisory-board/)) | | | [[medical_technology_companies:Complete Genomics]] | Advisory board member((//Advisory Board.// Complete Genomics. Retrieved November 27, 2022, from https://web.archive.org/web/20221127145415/https://www.completegenomics.com/about-us/complete-genomics-advisory-board/)) | |
| | [[Consortium for Space Genetics]] | Faculty member((//George M. Church, Ph.D.// Consortium for Space Genetics. Retrieved January 12, 2023, from https://archive.ph/MI26l)) | | | [[Consortium for Space Genetics]] | Faculty member((//George M. Church, Ph.D.// Consortium for Space Genetics. Retrieved January 12, 2023, from https://archive.ph/MI26l)) | |
| | | [[CRISPR Journal]] | - | |
| | [[Duke University]] | Researcher | | | [[Duke University]] | Researcher | |
| | [[Effective Altruism Global]] | Speaker at EA Global Boston in 2017((//Home.// EA Global Boston. Retrieved January 13, 2023, from https://web.archive.org/web/20230113035038/https://boston.eaglobal.org/)) ((Labenz, A. (2017, April 1). //Applications are open for EA Global Boston.// Effective Altruism Forum. https://web.archive.org/web/20221207211135/https://forum.effectivealtruism.org/posts/Rh5a5CHhpP955Winn/applications-are-open-for-ea-global-boston)) | | | [[Effective Altruism Global]] | Speaker at EA Global Boston in 2017((//Home.// EA Global Boston. Retrieved January 13, 2023, from https://web.archive.org/web/20230113035038/https://boston.eaglobal.org/)) ((Labenz, A. (2017, April 1). //Applications are open for EA Global Boston.// Effective Altruism Forum. https://web.archive.org/web/20221207211135/https://forum.effectivealtruism.org/posts/Rh5a5CHhpP955Winn/applications-are-open-for-ea-global-boston)) | |
| | | [[Fidelity]] | - | |
| | [[Flagship Pioneering]] | "Friend", Founder of many companies funded by Flagship((//From Primordial Soup to Nanopores: A Conversation With George Church.// (2018, November 5). Flagship Pioneering. https://web.archive.org/web/20230115044446/https://www.flagshippioneering.com/stories/q-a-with-george-church)) | | | [[Flagship Pioneering]] | "Friend", Founder of many companies funded by Flagship((//From Primordial Soup to Nanopores: A Conversation With George Church.// (2018, November 5). Flagship Pioneering. https://web.archive.org/web/20230115044446/https://www.flagshippioneering.com/stories/q-a-with-george-church)) | |
| | | [[Founders Fund]] | - | |
| | [[Franklin Institute]] | Bower Award and Prize for Achievement in Science((//Bower Laureates.// The Franklin Institute. Retrieved January 13, 2023, from https://web.archive.org/web/20230113001037/https://www.fi.edu/bower-laureates)) | | | [[Franklin Institute]] | Bower Award and Prize for Achievement in Science((//Bower Laureates.// The Franklin Institute. Retrieved January 13, 2023, from https://web.archive.org/web/20230113001037/https://www.fi.edu/bower-laureates)) | |
| | [[Future of Life Institute]] | External advisor((//George Church.// Future of Life Institute. Retrieved January 13, 2023, from https://archive.ph/w7Cez)) | | | [[Future of Life Institute]] | External advisor((//George Church.// Future of Life Institute. Retrieved January 13, 2023, from https://archive.ph/w7Cez)) | |
| | [[Genspace]] | Advisor((Loria, K. (2015, May 1). //The process used to edit the genes of human embryos is so easy you could do it in a community bio-hacker space.// Yahoo! Finance. https://archive.ph/nSTTa)) | | | [[Genspace]] | Advisor((Loria, K. (2015, May 1). //The process used to edit the genes of human embryos is so easy you could do it in a community bio-hacker space.// Yahoo! Finance. https://archive.ph/nSTTa)) | |
| | [[George Church Institute of Regenesis]] | Director((Bio-IT World Staff. (2017, October 27). //BGI Launches George Church Institute.// Bio-IT World. https://archive.ph/ufRYd)) | | | [[George Church Institute of Regenesis]] | Director((Bio-IT World Staff. (2017, October 27). //BGI Launches George Church Institute.// Bio-IT World. https://archive.ph/ufRYd)) | |
| | | [[Google Ventures]] | - | |
| | [[Harvard Alumni Entrepreneurs]] | Past speaker((//The Future of Synthetic Biology with Prof. George Church.// (2020, September 22). Harvard Alumni Entrepreneurs. https://archive.ph/v2QcV)) | | | [[Harvard Alumni Entrepreneurs]] | Past speaker((//The Future of Synthetic Biology with Prof. George Church.// (2020, September 22). Harvard Alumni Entrepreneurs. https://archive.ph/v2QcV)) | |
| | [[Harvard College Effective Altruism]] | Speaker((Eyal, N. (2014, October 18). //Harvard Effective Altruism: George Church this Monday.// Bill of Health. https://web.archive.org/web/20230113074847/https://blog.petrieflom.law.harvard.edu/2014/10/18/harvard-effective-altruism-george-church-this-monday/)) | | | [[Harvard College Effective Altruism]] | Speaker((Eyal, N. (2014, October 18). //Harvard Effective Altruism: George Church this Monday.// Bill of Health. https://web.archive.org/web/20230113074847/https://blog.petrieflom.law.harvard.edu/2014/10/18/harvard-effective-altruism-george-church-this-monday/)) | |
| | [[medical_technology_companies:Illumina]] | - | | | [[medical_technology_companies:Illumina]] | - | |
| | [[medical_technology_companies:INanoBio]] | Advisor((//Scientific Board of Advisors.// INanoBio. Retrieved December 8, 2018, from https://web.archive.org/web/20181208022354/http://www.inanobio.com:80/scientific-advisory-board.php)) | | | [[medical_technology_companies:INanoBio]] | Advisor((//Scientific Board of Advisors.// INanoBio. Retrieved December 8, 2018, from https://web.archive.org/web/20181208022354/http://www.inanobio.com:80/scientific-advisory-board.php)) | |
| | | [[In-Q-Tel]] | - | |
| | | [[Institute for Protein Innovation]] | - | |
| | [[medical_technology_companies:Intelligent Bio-Systems]] | Advisor((//Intelligent Bio-Systems - Contacts, Employees, Board Members, Advisors & Alumni.// Crunchbase. Retrieved January 13, 2023, from https://www.crunchbase.com/organization/intelligent-bio-systems/people)) | | | [[medical_technology_companies:Intelligent Bio-Systems]] | Advisor((//Intelligent Bio-Systems - Contacts, Employees, Board Members, Advisors & Alumni.// Crunchbase. Retrieved January 13, 2023, from https://www.crunchbase.com/organization/intelligent-bio-systems/people)) | |
| | [[medical_technology_companies:Ion Torrent]] | Advisor((//Scientific Advisory Board.// Ion Torrent. Retrieved January 14, 2012, from https://web.archive.org/web/20120114061324/http://www.iontorrent.com/scientific-advisory-board)) | | | [[medical_technology_companies:Ion Torrent]] | Advisor((//Scientific Advisory Board.// Ion Torrent. Retrieved January 14, 2012, from https://web.archive.org/web/20120114061324/http://www.iontorrent.com/scientific-advisory-board)) | |
| | [[Jeffrey Epstein VI Foundation]] | Research funding((Church, G. M. (2017, March 25). //Tech transfer.// Church Lab. https://archive.ph/XKy12)) | | | [[Jeffrey Epstein VI Foundation]] | Research funding((Church, G. M. (2017, March 25). //Tech transfer.// Church Lab. https://archive.ph/XKy12)) | |
| | | [[Life Extension Advocacy Foundation]] (LEAF) | - | |
| | [[Life Sciences Research Foundation]] | Fellow | | | [[Life Sciences Research Foundation]] | Fellow | |
| | [[Lipper Center for Computational Genetics]] | Director | | | [[Lipper Center for Computational Genetics]] | Director | |
| | | [[Longevity Vision Fund]] | - | |
| | [[pharmaceutical_companies:Lynx Therapeutics]] | Advisor((//Lynx Augments Its Intellectual Property Portfolio.// (2000, January 20). The Free Library. https://web.archive.org/web/20120908062001/http://www.thefreelibrary.com/Lynx+Augments+Its+Intellectual+Property+Portfolio.-a058723058)) | | | [[pharmaceutical_companies:Lynx Therapeutics]] | Advisor((//Lynx Augments Its Intellectual Property Portfolio.// (2000, January 20). The Free Library. https://web.archive.org/web/20120908062001/http://www.thefreelibrary.com/Lynx+Augments+Its+Intellectual+Property+Portfolio.-a058723058)) | |
| | [[Massachusetts Institute of Technology]] (MIT) | Professor((//George M. Church.// (2022, December 15). Harvard Molecular Technologies. https://web.archive.org/web/20230112232239/https://arep.med.harvard.edu/gmc/)) | | | [[Massachusetts Institute of Technology]] (MIT) | Professor((//George M. Church.// (2022, December 15). Harvard Molecular Technologies. https://web.archive.org/web/20230112232239/https://arep.med.harvard.edu/gmc/)) | |
| | [[National Academy of Future Physicians and Medical Scientists]] | Past speaker((//Speakers at the Congress of Future Medical Leaders - Offical Site.// National Academy of Future Physicians and Medical Scientists. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024545/https://www.futuredocs.com/speakers)) | | | [[National Academy of Future Physicians and Medical Scientists]] | Past speaker((//Speakers at the Congress of Future Medical Leaders - Offical Site.// National Academy of Future Physicians and Medical Scientists. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024545/https://www.futuredocs.com/speakers)) | |
| | [[National Academy of Sciences]] (NAS) | Member((Nair, P. (2012). //Profile of George M. Church.// Proceedings of the National Academy of Sciences, 109(30), 11893–11895. https://doi.org/10.1073/pnas.1204148109)) | | | [[National Academy of Sciences]] (NAS) | Member((Nair, P. (2012). //Profile of George M. Church.// Proceedings of the National Academy of Sciences, 109(30), 11893–11895. https://doi.org/10.1073/pnas.1204148109)) | |
| | | [[Nature Publishing Group]] | - | |
| | [[medical_technology_companies:Noblegen Biosciences]] | Advisor((//Advisors.// Noblegen Biosciences. Retrieved February 18, 2015, from https://web.archive.org/web/20150218153814/http://noblegenbio.com/Advisors.html)) | | | [[medical_technology_companies:Noblegen Biosciences]] | Advisor((//Advisors.// Noblegen Biosciences. Retrieved February 18, 2015, from https://web.archive.org/web/20150218153814/http://noblegenbio.com/Advisors.html)) | |
| | | [[Northeast Science Station]] | - | |
| | | [[Open Humans]] | - | |
| | [[Personal Genome Project]] (PGP) | Director | | | [[Personal Genome Project]] (PGP) | Director | |
| | [[pharmaceutical_companies:Poseida Therapeutics]] | Gene Therapy Scientific Advisory Board Chair((//George M. Church, Ph.D.// Poseida Therapeutics. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024849/https://poseida.com/george-m-church-ph-d/)) | | | [[pharmaceutical_companies:Poseida Therapeutics]] | Gene Therapy Scientific Advisory Board Chair((//George M. Church, Ph.D.// Poseida Therapeutics. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024849/https://poseida.com/george-m-church-ph-d/)) | |
| | | [[Rady Children's Institute for Genomic Medicine]] | - | |
| | | [[pharmaceutical_companies:Regenerative Bio]] | - | |
| | [[medical_technology_companies:Roswell Biotechnologies]] | Advisor((Roswell Biotechnologies, Inc. (2021, October 28). //Roswell Biotechnologies Forms Scientific Advisory Board.// PR Newswire. https://web.archive.org/web/20230114190637/https://www.prnewswire.com/news-releases/roswell-biotechnologies-forms-scientific-advisory-board-301410793.html)) | | | [[medical_technology_companies:Roswell Biotechnologies]] | Advisor((Roswell Biotechnologies, Inc. (2021, October 28). //Roswell Biotechnologies Forms Scientific Advisory Board.// PR Newswire. https://web.archive.org/web/20230114190637/https://www.prnewswire.com/news-releases/roswell-biotechnologies-forms-scientific-advisory-board-301410793.html)) | |
| | | [[Scientific American]] | - | |
| | [[medical_technology_companies:Solexa]] | - | | | [[medical_technology_companies:Solexa]] | - | |
| | [[Supercentenarian Research Study]] | Scientific Advisor((//About Us.// Supercentenarian Research Study. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074556/https://supercentenarianstudy.com/aboutus.html)) | | | [[Supercentenarian Research Study]] | Scientific Advisor((//About Us.// Supercentenarian Research Study. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074556/https://supercentenarianstudy.com/aboutus.html)) | |
| | [[United States Department of Energy]] | Funding | | | [[United States Department of Energy]] | Funding | |
| | [[University of California San Francisco]] | Post-doctoral researcher | | | [[University of California San Francisco]] | Post-doctoral researcher | |
| | | [[Winklevoss Capital]] | - | |
| | [[Wyss Institute for Biologically Inspired Engineering]] | Director | | | [[Wyss Institute for Biologically Inspired Engineering]] | Director | |
| | [[medical_technology_companies:XGenomes]] | Advisor((Shieber, J. (2019, March 15). //XGenomes is bringing DNA sequencing to the masses.// TechCrunch. https://archive.ph/a6ErD)) | | | [[medical_technology_companies:XGenomes]] | Advisor((Shieber, J. (2019, March 15). //XGenomes is bringing DNA sequencing to the masses.// TechCrunch. https://archive.ph/a6ErD)) | |
| | | [[XPRIZE]] | - | |
| | | [[Y Combinator]] | - | |
| | [[Zhejiang University]] | Honorary Professor((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj)) | | | [[Zhejiang University]] | Honorary Professor((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj)) | |
| |